Your browser doesn't support javascript.
loading
Novel insights into causal effects of maternal nonalcoholic fatty liver disease on adverse pregnancy outcomes: evidence from Human Genetics and Mendelian Randomization Study.
Luo, Qiuyan; Liu, Guoting; Li, Qiulan; Lu, Jinghong; Zheng, Wenjing; Huang, Yukui; Li, Cun.
Affiliation
  • Luo Q; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China.
  • Liu G; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China.
  • Li Q; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China.
  • Lu J; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China.
  • Zheng W; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China.
  • Huang Y; Department of Obstetrics and Gynecology, Nanning Maternity and Child Health Hospital, Nanning, PR China. hyk88@126.com.
  • Li C; Department of Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, PR China. licun@sr.gxmu.edu.cn.
Eur J Clin Nutr ; 2024 Aug 15.
Article de En | MEDLINE | ID: mdl-39147848
ABSTRACT

BACKGROUND:

Observational studies have associated nonalcoholic fatty liver disease (NAFLD) with adverse pregnancy events, but findings show heterogeneity, leaving the causal direction and mediating pathways unclear. We aimed to investigate the causal relation between NAFLD and various pregnancy events, and to elucidate the underlying mediating pathways while determining the proportion of this correlation that is mediated through these pathways.

METHODS:

A genome-wide association study involving over 6 million participants employing Mendelian randomization (MR) and mediation analysis was performed. The study used genetically predicted NAFLD as exposures and cardiometabolic traits as mediators, with various adverse pregnancy events as outcomes. The main analysis was performed using the inverse variance weighted (IVW) approach, while sensitivity analyses included the weighted median, weighted mode, MR-Egger, and MR-PRESSO methods. Mediation analyses were performed using a two-step MR framework.

RESULTS:

In this MR cohort study, NAFLD was found to be strongly associated with elevated risks of GDM (P = 0.019 for the discovery dataset, P < 0.001 for the discovery dataset) and HDPs, including any HDP (P < 0.001 for the both datasets), gestational hypertension (P = 0.007 for the discovery dataset, P < 0.001 for the discovery dataset), and pre-eclampsia or eclampsia (P = 0.040 for the discovery dataset, P < 0.001 for the discovery dataset). However, no significant associations were found with hemorrhage in early pregnancy, postpartum hemorrhage, preterm birth, or offspring birthweight for both datasets. Cardiometabolic traits played a significant mediating role in these associations, rather than solely acting as confounding factors.

CONCLUSIONS:

This study provided evidence supporting a correlation between NAFLD and a higher risk of adverse pregnancy events and introduces some new insights. These findings may inform preventions and interventions for remediating adverse pregnancy outcomes attributable to NAFLD.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur J Clin Nutr Sujet du journal: CIENCIAS DA NUTRICAO Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur J Clin Nutr Sujet du journal: CIENCIAS DA NUTRICAO Année: 2024 Type de document: Article Pays de publication: Royaume-Uni